Abiomed losses narrow for Q3, bolstered by strong Impella sales

Justine Varieur Cadet | | Cardiovascular Business | Interventional Cardiology
Abiomed, a developer of heart recovery products providing circulatory support to acute heart failure patients, trimmed losses and upped revenues for its fiscal 2009 third quarter, which ended Dec. 31, 2008.

The Danvers, Mass.-based company booked a net loss of $700,000 for the third quarter of 2009, a sharp turnaround compared with a net loss of $8.3 million in the third quarter of fiscal 2008.

The firm said its Impella (a minimally invasive, catheter-based cardiac assist device) revenue was $8.9 million, up 112 percent for the  period compared with the same quarter last year

For the quarter, the company booked total revenue of $17.3 million, up 8 percent compared with revenue of $16 million for the same period last year, according to Abiomed.

Justine Varieur Cadet

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."